SAR of a Series of 5,6-Dihydro-(9H)-pyrazolo3,4-c-1,2,4-triazolo4,3-alphapyridines as Potent Inhibitors of Human Eosinophil Phosphodiesterase

摘要

The potency and physical properties of a previously reported 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo3,4-c-pyridine series of human eosinophil phosphodiesterase inhibitors were improved by tying the lactam moiety into a triazolo ring.The resulting 5,6-dihydro-(9H)-pyrazolo3,4-c-1,2,4-triazolo4,3-alphapyridine series provided nonionizable analogs with melting point properties suitable for micronization.Substitution at the 3-position of the 5,6-dihydro-(9H)-pyrazolo3,4-c-1,2,4-triazolo4,3-alphapyridine tricycle led to a 2-thienyl analog,19 (tofimilast),a potent PDE4 inhibitor with low oral bioavailability and no emesis-associated behaviors in ferrets at plasma concentrations up to 152 ng/mL.